Current Affairs

Fresh Data Bolster TYK2 Blocker for Psoriatic Arthritis

(MedPage Today) – Barcelona – Decravacitinib (Sotyktu) Approved by the final test as a treatment for psoriasis arthritis (PSA), which indicates the superiority of the fake medicine for most of the end points, according to a presentation …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button